Foundations Investment Advisors LLC Has $1.39 Million Stock Holdings in CVS Health Corporation $CVS

Foundations Investment Advisors LLC boosted its position in CVS Health Corporation (NYSE:CVS) by 97.9% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 18,473 shares of the pharmacy operator’s stock after purchasing an additional 9,140 shares during the period. Foundations Investment Advisors LLC’s holdings in CVS Health were worth $1,393,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of CVS. AE Wealth Management LLC raised its stake in CVS Health by 6.2% in the third quarter. AE Wealth Management LLC now owns 257,204 shares of the pharmacy operator’s stock valued at $19,391,000 after buying an additional 14,983 shares during the period. Birchbrook Inc. increased its holdings in shares of CVS Health by 4.1% during the 3rd quarter. Birchbrook Inc. now owns 6,034 shares of the pharmacy operator’s stock worth $455,000 after acquiring an additional 239 shares during the last quarter. Fidelis Capital Partners LLC raised its stake in CVS Health by 2.6% in the 3rd quarter. Fidelis Capital Partners LLC now owns 16,731 shares of the pharmacy operator’s stock valued at $1,261,000 after acquiring an additional 417 shares during the period. Annis Gardner Whiting Capital Advisors LLC lifted its holdings in CVS Health by 367.8% during the 3rd quarter. Annis Gardner Whiting Capital Advisors LLC now owns 4,528 shares of the pharmacy operator’s stock valued at $341,000 after purchasing an additional 3,560 shares during the last quarter. Finally, TD Waterhouse Canada Inc. increased its holdings in shares of CVS Health by 2.4% in the third quarter. TD Waterhouse Canada Inc. now owns 336,081 shares of the pharmacy operator’s stock valued at $24,334,000 after purchasing an additional 7,721 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Price Performance

CVS Health stock opened at $74.51 on Friday. The firm has a market cap of $94.59 billion, a PE ratio of 196.09, a price-to-earnings-growth ratio of 0.68 and a beta of 0.48. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. The stock’s fifty day moving average price is $78.90 and its two-hundred day moving average price is $75.16. CVS Health Corporation has a one year low of $53.36 and a one year high of $85.15.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.CVS Health’s quarterly revenue was up 7.8% on a year-over-year basis. During the same period in the prior year, the firm posted $1.09 EPS. As a group, research analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd will be paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.6%. The ex-dividend date is Thursday, January 22nd. CVS Health’s dividend payout ratio is presently 700.00%.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. Barclays raised their target price on shares of CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 10th. Cantor Fitzgerald restated an “overweight” rating on shares of CVS Health in a report on Wednesday, December 10th. Jefferies Financial Group upped their target price on CVS Health from $92.00 to $98.00 in a research report on Thursday, October 30th. The Goldman Sachs Group lifted their price target on CVS Health from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Wednesday, December 10th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a report on Monday, December 29th. Nineteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $94.82.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.